INTRODUCTION
Streptococcus pneumoniae remains a major cause of disease worldwide [1] .
Among pneumonia pathogens, it is the most common cause of hospitalisation in adults and the most frequent cause of death [2, 3] . Despite continuing improvements in etiologic diagnosis, effective antibiotic therapy and advances in supportive care, mortality rates in patients with pneumococcal pneumonia remain high, ranging from 5 to 35% [4] .
Septic shock at admission is one of the most important factors influencing prognosis of patients with pneumococcal pneumonia. It is known that the intrinsic relationship between the host and the microorganism is critical in the pathogenesis of septic shock [5] . Many host factors influence the ability to develop an optimal immune response against infection.
Moreover, more than 90 serotypes of pneumococci have been described, defined by differences in the polysaccharide capsule [6] , the major virulence determinant of these organisms [7] . The improvement in the knowledge of serotypes associated with septic shock may help in the design of new vaccines. However, within serotypes different genotypes may be identified [8] [9] [10] [11] and these genotypes are associated with the presence of different virulence determinants. The association between infecting S. pneumoniae genotype and pneumonia severity has not been well established.
To date, little information regarding the host-and pathogen-related factors associated with pneumococcal pneumonia presenting with septic shock is available. We performed this prospective study to identify risk factors for septic shock and to ascertain clinical outcomes in a large and homogeneous cohort of non-severely immunosuppressed hospitalised adults
METHODS

Setting, patients, and study design
The study was carried out in a 900-bed university hospital for adults in Barcelona, Spain. The hospital serves an area of 1,000,000 inhabitants and admits approximately 24,000 patients per year. All non-severely immunosuppressed adults admitted to the hospital with pneumococcal pneumonia through the emergency department from February 13, 1995 through June 30, 2008 were prospectively recruited and followed up. Patients with neutropenia, HIV infection, and transplantation were not included.
For the purposes of this study patients were divided into two groups: patients who presented with septic shock at admission and those who did not (henceforth "pneumococcal pneumonia with shock" and "pneumococcal pneumonia without shock").
Clinical evaluation and follow-up
At the initial visit, before starting empirical antibiotic therapy, patients underwent a complete clinical history and physical examination.
Microbiological studies included two sets of blood cultures and sputum Gram stain and culture when available. Urinary antigen detection for S.
pneumoniae was performed if indicated by the attending physician. Patients were stratified into risk classes by using the validated prediction rule calculated according to the Pneumonia Severity Index (PSI) scores, as described elsewhere [12] .
Empirical antibiotic therapy was administered according to the hospital guidelines, which recommend the administration of a ß-lactam agent (ceftriaxone or amoxicillin-clavulanate) with or without macrolide or a fluoroquinolone. Combination therapy was recommended for patients with clinical suspicion of Legionella or an atypical pathogen or in the case of severe pneumonia in the absence of a demonstrative sputum Gram stain.
Levofloxacin monotherapy was allowed for selected cases (i.e., patients with allergy to ß-lactam agents and no prior quinolone use).
Patients were seen daily during their hospital stay by one or more of the investigators who provided medical advice when requested and recorded clinical and microbiological data in a computer-assisted protocol. The diagnosis of septic shock was based on a systolic blood pressure of less than 90 mmHg and peripheral hypoperfusion with the need for vasopressors for >4 hrs after fluid replacement at admission. Current tobacco smoking was recorded when a patient had smoked more than ten cigarettes per day for at least 1 year preceding the study, and alcohol consumption group.bmj.com on April 28, 2017 -Published by http://thorax.bmj.com/ Downloaded from when a patient had consumed more than 80 g of alcohol daily for at least 1 year preceding the study. Chronic corticosteroid treatment was defined as ≤20 mg/day of prednisone or its equivalent for a period of at least 30 days; patients receiving higher doses were excluded. A patient was considered to have been pneumococcal-vaccinated if 23-valent polysaccharide pneumococcal vaccine had been administered in the five years before admission, according to the hospital and primary healthcare centre records.
Definitions
A patient was considered influenza-vaccinated if influenza vaccine had been administered during the year prior to admission.
Early case-fatality rate was defined as death due to any cause ≤48 hours after hospitalisation. Overall case-fatality rate was defined as death due to any cause ≤30 days of hospitalisation.
Microbiological studies
S. pneumoniae was identified using standard microbiology procedures. From 2000 onwards, urinary antigen detection using a rapid immunochromatographic assay (Now TM , Binax, Portland, ME, USA) for
Streptococcus pneumoniae was also available. Antimicrobial susceptibility was tested by microdilution method, following the Clinical Laboratory
Standard Institute methods and criteria [13, 14] .
Serotype was identified using the Quellung reaction at the Spanish Reference Laboratory [15] and/or by PCR following the methodology described by CDC (http://www.cdc.gov/ncidod/biotech/strep/strepindex.htm).
Unusual serotype/genotype combinations were retested.
group.bmj.com on April 28, 2017 -Published by http://thorax.bmj.com/ Downloaded from For molecular typing, all available strains were typed using pulsed field gel electrophoresis (PFGE) after restriction with SmaI. PFGE patterns were compared with those of representative international pneumococcal clones of the Pneumococcal Molecular Epidemiology Network [16] . Sixty-six selected strains representative of main clusters (at least one strain for each PFGE pattern accounting for >2 pneumococci) were studied using multilocus sequence typing, as described elsewhere [11] . Allele numbers and sequence types (STs) were assigned using the pneumococcal multilocus sequence typing Web site.
Statistical analysis
To detect significant differences between groups, we used the chi- 
RESULTS
Over the study period, 1041 consecutive adults with pneumococcal pneumonia were included, of whom 114 (10.9%) had septic shock at admission. Table 1 details the microbiological methods used to establish the diagnosis of pneumococcal pneumonia.
Clinical features of the patients according to the study group (pneumococcal pneumonia presenting with shock and pneumococcal pneumonia without shock) are shown in table 2. Patients with shock were significantly younger, were more frequently current smokers, had more frequently received chronic corticosteroid therapy, and were less likely to have received prior influenza vaccine than patients without shock. They also had more frequent respiratory failure, multilobar pneumonia and impaired consciousness at admission and were more commonly classified into highrisk PSI classes than those without.
Antibiotic-resistant pneumococci with a penicillin MIC ≥4 μg/mL (1.5% versus 1.7%; P =1) and a cefotaxime MIC of 1 μg/mL (0% versus 1.9%; P =.617) were distributed equally between groups. No differences in the rates of resistance to erythromycin (11.8% vs. 16 in patients with shock. This group also required mechanical ventilation more frequently, and had longer length of hospital stay. Moreover, the early and overall case-fatality rates were higher in patients who had septic shock at admission. 
DISCUSSION
This prospective study offers a comprehensive evaluation of the hostand pathogen-related risk factors associated with septic shock in pneumococcal pneumonia. We found that 10.9% of patients had septic shock at admission, a figure similar to that encountered in previous studies of community-acquired pneumonia, in which the incidence of septic shock ranged from 7.4 to 10%. [12, 17] .
In our study, independent factors for septic shock were current tobacco smoking, chronic corticosteroid therapy, and infection caused by S. pneumoniae serotype 3. Neither infecting genotype nor antibiotic resistance were found to be associated with septic shock.
Tobacco smoking has been previously associated with increased risk of infection [18] [19] [20] [21] , especially invasive pneumococcal disease [2, 22] . It has been demonstrated that smoking negatively affects the immune system, compromising the host's ability to mount appropriate immune and inflammatory response [23] [24] [25] . To our knowledge, our study is the first to directly link current tobacco smoking with septic shock in pneumococcal pneumonia. This finding provides additional support to encourage patients at risk for pneumonia to undergo smoking cessation programs.
Glucocorticoids exert a decisive influence in the immune function of macrophages and granulocytes, as well as in the systemic cytokine expression. Additionally, chronic corticosteroid therapy suppresses the production of corticotropin-releasing hormone and corticotropin and can induce adrenal atrophy [26] . Consequently, the adrenal responses to infection may be insufficient to control the inflammatory situation. Although group.bmj.com on April 28, 2017 -Published by http://thorax.bmj.com/ Downloaded from evidence from randomised trials is lacking, treatment with supplementary corticosteroids may be of benefit in patients with pneumococcal pneumonia and septic shock in whom there is evidence of adrenal insufficiency.
Serotype 3 is usually associated with adult pneumococcal infection and is less frequent in children and in young adults. In our study it caused nearly one in four of the cases of pneumococcal pneumonia. Interestingly, we found that serotype 3 was independently associated with septic shock.
Previous studies associated serotype 3 with a low invasive potential but with higher mortality rates in bacteraemic pneumococcal pneumonia [27] [28] [29] [30] [31] [32] [33] .
Probably, within serotype 3 isolates, the genetic background plays an important role in virulence. In our study, two main genotypes were found among serotype 3 strains (ST260 and ST180) and no significant differences were observed among patients with or without shock at presentation. previously demonstrated that the introduction of PVC7 has changed the serotypes causing invasive pneumococcal disease in adults [1] . Importantly, the upcoming PCV 13-valent includes this serotype and might help to prevent septic shock in pneumococcal pneumonia. Moreover, in the future the PCV13 vaccine will be available for adult vaccination.
It is known that Influenza virus alters the lungs in a way that predisposes to adherence, invasion, and induction of disease by pneumococcus [34] . It has been documented that prior influenza vaccination group.bmj.com on April 28, 2017 -Published by http://thorax.bmj.com/ Downloaded from prevents pneumonia hospitalizations and has a substantial effect on allcause mortality [34] . In our study, although influenza vaccination was found to be a protective factor for septic shock in the univariate analysis, this finding missed significance in the final model.
We found that patients presenting with septic shock required mechanical ventilation more frequently and had longer length of hospital stay than patients without shock. As expected, these patients had high early and overall case-fatality rates. These findings corroborate those of previous studies [12, 35, 36] .
Despite a number of strengths, our study has some limitations that should be acknowledge. First, the possible role of polymorphisms of innate immunity was not analysed. Investigating the relationship between immune system genetics and the severity of infection should therefore be a major focus of future research. Second, the small number of pneumonias caused by some serotypes and genotypes precluded analysing their potential correlation with shock. Third, the study was carried out in a single centre and the results might not been translated to other geographic areas.
In summary, septic shock is a frequent complication of pneumococcal pneumonia and causes high morbidity and mortality. Current tobacco smoking, chronic corticosteroid therapy, and infection caused by serotype 3 are independent risk factors for this serious complication. 
